Work

Kardia-3: Zilebesiran as Add-on Therapy in Adults With Hypertension and Established Cardiovascular Disease or High Cardiovascular Risk With and Without Chronic Kidney Disease

Year: 2026

Type: article

Study design: Clinical Trial

Source: Journal of Hypertension

DOI: 10.1097/01.hjh.0001197492.36993.cc

Authors: Neha Pagidipati, Michael Weber, Manish Saxena, Bryan Williams, Shaun G Goodman, Zhihua Xiang, Shruti Daga, Monica Bengus, Dion Zappe, Ishir Bhan, Christopher B Granger

Institutions: Duke Clinical Research Institute, SUNY Downstate Health Sciences University, Queen Mary University of London, Barts Health NHS Trust, University College London, St. Michael's Hospital, University of Alberta, University of Toronto, Canadian VIGOUR Centre, Alnylam Pharmaceuticals (United States), Roche (United Kingdom), F. Hoffmann-La Roche AG

Language: English

Topic: Blood Pressure and Hypertension Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7163025997

FWCI: 13.82

Cites:

Cited by: 4

Related to: 10